Inovio Pharmaceuticals
INO
S$1.90
Share price
0.68%
Change (1 day)
-86.96%
Change (1 year)
Categories
Revenue for Inovio Pharmaceuticals (INO)
Revenue in 2025 (TTM): S$0.38 Million
According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is S$0.36 Million. In 2024 the company made a revenue of S$0.29 Million a decrease over the revenue in the year 2023 that were of S$1.09 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Inovio Pharmaceuticals from 1999 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | S$0.38 M | 29.5% |
| 2024 | S$0.29 M | -73.06% |
| 2023 | S$1.09 M | -92.01% |
| 2022 | S$13.75 M | 473.4% |
| 2021 | S$2.39 M | -75.53% |
| 2020 | S$9.8 M | 76.86% |
| 2019 | S$5.54 M | -86.69% |
| 2018 | S$41.64 M | -26.26% |
| 2017 | S$56.46 M | 10.32% |
| 2016 | S$51.18 M | -10.81% |
| 2015 | S$57.39 M | 315.36% |
| 2014 | S$13.81 M | -19.02% |
| 2013 | S$17.06 M | 238.77% |
| 2012 | S$5.03 M | -60.3% |
| 2011 | S$12.68 M | 60.27% |
| 2010 | S$7.91 M | -38.18% |
| 2009 | S$12.8 M | 326.82% |
| 2008 | S$2.99 M | -56.64% |
| 2007 | S$6.91 M | 30.09% |
| 2006 | S$5.31 M | -41.58% |
| 2005 | S$9.1 M | 378.1% |
| 2004 | S$1.9 M | 1291.63% |
| 2003 | S$0.13 M | -58.39% |
| 2002 | S$0.32 M | |
| 2000 | S$9.64 M | -34.16% |
| 1999 | S$14.65 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | S$80.33 B | 22,063,912.94% | 🇺🇸 USA |
 Johnson & Johnson JNJ | S$114.88 B | 31,554,585.82% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | S$0.70 B | 192,485.99% | 🇺🇸 USA |
 Novartis NVS | S$68.44 B | 18,799,683.82% | 🇨🇭 Switzerland |
 Merck MRK | S$82.21 B | 22,579,280.36% | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$52.19 B | 14,336,433.75% | 🇬🇧 UK |
 Gilead Sciences GILD | S$36.95 B | 10,149,706.25% | 🇺🇸 USA |
 Cleveland BioLabs
CBLI | S$0.81 M | 123.19% | 🇺🇸 USA |